Prospective prevalence of pathologic gambling and medication association in Parkinson disease.
The authors prospectively screened 297 patients with Parkinson disease (PD), who attended a tertiary clinic, using a modified South Oaks Gambling Scale. Lifetime prevalence of pathologic gambling (PG) was 3.4% and on any dopamine agonist was 7.2%. PG was associated with earlier PD onset and with dopamine agonists but not with agonist subtype or doses. We found no association with a potent D3 receptor agonist.
Voon
V
V
Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-1428, USA. voonv@ninds.nih.gov
Hassan
K
K
Zurowski
M
M
Duff-Canning
S
S
de Souza
M
M
Fox
S
S
Lang
A E
AE
Miyasaki
J
J
D000368:Aged; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D015259:Dopamine Agents / Q000627:therapeutic use*; D005260:Female; D005715:Gambling; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009864:Ontario / Q000453:epidemiology; D010300:Parkinson Disease / Q000188:drug therapy* / Q000453:epidemiology*; D015995:Prevalence; D011446:Prospective Studies; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors
D000978:Antiparkinson Agents; D015259:Dopamine Agents; D007980:Levodopa